STATE STREET CORP - TITAN PHARMACEUTICALS INC DE ownership

TITAN PHARMACEUTICALS INC DE's ticker is TTNP and the CUSIP is 888314606. A total of 28 filers reported holding TITAN PHARMACEUTICALS INC DE in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
STATE STREET CORP ownership history of TITAN PHARMACEUTICALS INC DE
ValueSharesWeighting
Q3 2023$17,811
-28.2%
38,2870.0%0.00%
Q2 2023$24,810
-21.8%
38,2870.0%0.00%
Q1 2023$31,709
-47.1%
38,287
-50.0%
0.00%
Q4 2022$59,966
+46.3%
76,574
+100.0%
0.00%
Q3 2022$41,00038,2870.00%
Other shareholders
TITAN PHARMACEUTICALS INC DE shareholders Q3 2023
NameSharesValueWeighting ↓
ARMISTICE CAPITAL, LLC 863,512$826,0000.02%
Level Financial Advisors 987$1,0000.00%
Westside Investment Management, Inc. 4$00.00%
Fortitude Advisory Group L.L.C. 8$00.00%
American Portfolios Advisors 23$220.00%
Renaissance Technologies 36,510$35,0000.00%
BARCLAYS PLC 50,050$48,0000.00%
VANGUARD GROUP INC 206,428$197,0000.00%
UBS Group AG 7,123$7,0000.00%
IFP Advisors, Inc 844$3,0000.00%
View complete list of TITAN PHARMACEUTICALS INC DE shareholders